Billionaire Profile
Liu Gexin & family
Global Rank
#2303

Image: Unsplash Contributor | Unsplash License | via Unsplash

Liu Gexin & family

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$1.806B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-3.3% (24h)
Age
75
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Liu Gexin is the chairman of Sichuan Kelun Pharmaceutical, a major pharmaceutical company in China. He is the founder and Executive Chairman of Tecon Group. Liu's career began in the veterinary medicine field and then he transitioned into pharmaceuticals and the agribusiness sector. His wealth is primarily derived from his ownership in Sichuan Kelun Pharmaceutical and the success of the Tecon Group, which operates in the animal health industry. His focus is on scientific innovation, scale manufacturing and vertical integration. He has a net worth of $1.6 Billion as of 2024, and is ranked #2413 globally.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Born in 1951, Liu Gexin began his career in the veterinary medicine field, graduating with a degree in Veterinary Medicine.

Rise to Success

Liu ventured into business in 1996, founding Kelun Pharmaceutical Factory, which later became Sichuan Kelun Pharmaceutical. The company initially produced intravenous solutions and grew to dominate the domestic market for this essential medical product. This foundational business provided the cash flow for significant expansion and diversification. Liu also serves as the chairman of China Keli Group, which holds the controlling stake in Sichuan Kelun Pharmaceutical.

Key Business Strategies

Liu's strategic approach emphasizes technological excellence and vertical integration. The expansion of Tecon Group was aggressive, successfully executing its IPO. Liu's wealth is secured by the colossal, long-term, stable profitability of the global agribusiness and veterinary pharmaceutical sector.

Philanthropy

Liu's social impact is structural, stemming from Tecon Group's role in providing essential veterinary medicines and vaccines that contribute to food safety and animal health in China. The company contributes significantly to the national agribusiness supply chain and food security. His personal philanthropy supports various community and educational initiatives.

Career Milestones

1992

General Manager

Sichuan Qili Pharmaceutical Co., Ltd.

1996

Founder

Kelun Pharmaceutical Factory

2005

Award

National Model Worker

2010

IPO

Kelun went public on the Shenzhen Stock Exchange

2017

Award

Top 10 Commercial Leaders in China's Pharmaceutical Industry